Article
SUMO operates from a unique long tandem repeat to keep innate immunity in check
19 Jul 2025
Abstract excerpt
The SUMO pathway mainly functions to repress innate immunity in myeloid cells. Inactivating sumoylation triggers a strong, noncanonical, type I interferon (IFN1) response, amplified and coupled with inflammation upon stimulation. These findings transposed to pre-clinical models with the demonstration that sumoylation inhibitors activate antitumor immunity in an IFN1-dependent manner. Yet, how sumoylation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
